Comparing efficacy of high-dose rate brachytherapy versus helical tomotherapy in the treatment of cervical cancer.
CONCLUSIONS: HT boost treatment showed comparable disease outcomes with those observed with conventional BT in patients with advanced cervical cancer. HT could be a complementary boost protocol as a single modality or hybrid with BT in selected patients. Further studies with longer follow-up periods are warranted to confirm long-term outcomes.
PMID: 32026658 [PubMed - as supplied by publisher]
Source: Journal of Gynecologic Oncology - Category: OBGYN Tags: J Gynecol Oncol Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | Cervical Cancer | Chemotherapy | External Beam Therapy | Gastroenterology | OBGYN | Study | Toxicology